Perrigo’s new leader backs generics plans

Perrigo’s newly-appointed president and chief executive officer, Murray Kessler, has backed the planned ‘separation’of the firm’s ‘Rx’ Prescription US generics operation, but has also praised the business’ potential, albeit in the face of a disappointing financial third quarter.